In the Materials and methods section of this paper, the amino acid sequence of the synthetic peptide that was used for immunization to prepare antibody against LC3 N-terminal region should be PSEKTFKQRRSFEQC, not PSDRPFKQRRSFADC as shown in the published paper. The authors would like to apologize for this error and for any confusion caused.
The oncogenic RAS2 val19 mutation locks respiration, independently of PKA, in a mode prone to generate ROS Lydie Hlavata Â , Hugo Aguilaniu, Alena Pichova Â and Thomas Nystro È m
The EMBO Journal, 22, 3337±3345, 2003 We have repeated all the respiration experiments in the above paper with lower concentrations of TET and CCCP (20±100 mM TET and 1±5 mM CCCP) since the concentrations originally used may potentially cause non-speci®c effects. Using the lower range of TET and CCCP concentrations, we ®nd that the respiratory state value (RSV) differences are still signi®cant (10.65 in the RAS2 val19 cells against 69.61 in wild-type cells). Thus, the conclusions of the paper remain unchanged. Nonetheless, the distinction should be made that the RAS2 val19 mutant shows a respiration closer to state 4 than the wild type but is not completely non-phosphorylating. The corrected RSV table (Table I ) is as follows: The EMBO Journal Vol. 22 No. 18 pp. 4577, 2003 ã European Molecular Biology Organization
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